QTTB compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name

QTTBQ32 Bio Inc.

Mkt capRevenueRevenue

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

QTTBQ32 Bio Inc.

OKUROnKure Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

QTTB2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±37.1%▲+2.40%×0.06

Q2 FY26±16.2%▲+2.07%×0.13

OKUR2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−2.51%—

Q2 FY26±80.0%▲+1.46%×0.02

= impliedQTTB realized, solidOKUR realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

QTTBQ32 Bio Inc.

9.26▲+4.58%· post 9.25

Mkt cap$276.8MRevenue$54MQ4 FY25

OKUROnKure Therapeutics, Inc.

2.85▲+12.97%· post 2.85

ClosedNov 6 '26

Mkt cap$116.0MRevenue—

Compare

ClosedNov 6 '26

QTTBQ32 Bio Inc.

OKUROnKure Therapeutics, Inc.

9.26▲+4.58%post 9.25

Price

2.85▲+12.97%post 2.85

$276.8M

Mkt cap

$116.0M

Q4 FY25$54M

Revenue

—

QTTB9.26▲+4.58%vsOKUR2.85▲+12.97%ClosedNov 6 '26